223 related articles for article (PubMed ID: 12434771)
1. General information about the validation of serological method (ELISA) for the batch potency testing erysipelas vaccines.
Altern Lab Anim; 2002; 30(5):486-7. PubMed ID: 12434771
[No Abstract] [Full Text] [Related]
2. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
[TBL] [Abstract][Full Text] [Related]
3. Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test.
Rosskopf-Streicher U; Johannes S; Wilhelm M; Cussler K
Vaccine; 2001 Jan; 19(11-12):1477-83. PubMed ID: 11163671
[TBL] [Abstract][Full Text] [Related]
4. Development of an enzyme-linked immunosorbent assay for potency testing of erysipelas bacterins.
Henderson LM; Scheevel KF; Walden DM
Dev Biol Stand; 1996; 86():333. PubMed ID: 8785973
[No Abstract] [Full Text] [Related]
5. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
[TBL] [Abstract][Full Text] [Related]
6. Development of an enzyme-linked immunosorbent assay for the serological detection of exposure of poultry in New Zealand to Erysipelothrix rhusiopathiae and their serological response to vaccination.
Kurian A; Neumann EJ; Hall WF; Christensen N
N Z Vet J; 2012 Mar; 60(2):100-5. PubMed ID: 22352927
[TBL] [Abstract][Full Text] [Related]
7. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
Beckmann R; Gyra H; Cussler K
Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
[No Abstract] [Full Text] [Related]
8. Effect of antibiotics on the immune system of animals. III. Experiments in pgis immunized with live and inactivated swine erysipelas vaccines.
Tu TD
Acta Vet Acad Sci Hung; 1981; 28(3):317-31. PubMed ID: 7258020
[No Abstract] [Full Text] [Related]
9. Induction of cross-protection in mice against dolphin Erysipelothrix rhusiopathiae isolates with a swine commercial vaccine.
Lacave G; Cox E; Hermans J; Devriese L; Goddeeris BM
Vet Microbiol; 2001 Jun; 80(3):247-53. PubMed ID: 11337140
[TBL] [Abstract][Full Text] [Related]
10. Effects of antibiotics on the immune system of animals. II. Mouse experiments with an inactivated adsorbed vaccine against swine erysipelas.
Tu TD
Acta Vet Acad Sci Hung; 1981; 28(3):309-16. PubMed ID: 7258019
[No Abstract] [Full Text] [Related]
11. Use of the protective antigen of Erysipelothrix rhusiopathiae in the enzyme-linked immunosorbent assay and latex agglutination.
Sato H; Yamazaki Y; Tsuchiya K; Aoyama T; Akaba N; Suzuki T; Yokoyama A; Saito H; Maehara N
Zentralbl Veterinarmed B; 1998 Sep; 45(7):407-20. PubMed ID: 9780828
[TBL] [Abstract][Full Text] [Related]
12. [Detection of Erysipelothrix rhusiopathiae specific antibodies in the serum of experimentally-infected swine by ELISA and immunoblotting].
Dahms H; Schilow WF; Hagemann G
Arch Exp Veterinarmed; 1989 Nov; 43(6):907-16. PubMed ID: 2619491
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a monoclonal antibody for in vitro potency testing of erysipelas bacterins.
Henderson LM; Jenkins PS; Scheevel KF; Walden DM
Dev Biol Stand; 1996; 86():334. PubMed ID: 8785974
[No Abstract] [Full Text] [Related]
14. [Onset and duration of immunity following aerogenic immunization of swine against swine pest and erysipelas].
Kaden V; Heller P; Polster U; Glaner M
Arch Exp Veterinarmed; 1985 Sep; 39(5):730-7. PubMed ID: 4074082
[No Abstract] [Full Text] [Related]
15. Response of growth agglutinating antibody and protection of pigs inoculated with swine erysipelas live vaccine.
Sawada T; Muramatsu M; Seto K
Nihon Juigaku Zasshi; 1979 Dec; 41(6):593-600. PubMed ID: 522336
[No Abstract] [Full Text] [Related]
16. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
[TBL] [Abstract][Full Text] [Related]
17. [Immunity of native SpaA and recombinant SpaA-N against Erysipelothrix rhusiopathiae infection in mice].
Nazierbieke W; Zhang L; He C; Peng Q; Borrathybay E
Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):367-72. PubMed ID: 20499642
[TBL] [Abstract][Full Text] [Related]
18. [Studies of the occurrence of erysipelas bacteria in healthy swine in the Hungarian People's Republic with reference to possible use of erysipelas live vaccines].
Kucsera G
Arch Exp Veterinarmed; 1980; 34(1):63-5. PubMed ID: 7416896
[TBL] [Abstract][Full Text] [Related]
19. [Aerogenic immunization against swine erysipelas with Spirovak erysipelas vaccine "Dessau"].
Urbaneck D; Stöhr P; Michael-Meese M
Arch Exp Veterinarmed; 1980; 34(1):51-4. PubMed ID: 7416893
[TBL] [Abstract][Full Text] [Related]
20. Potency testing of inactivated erysipelas vaccines by ELISA--influence of the adjuvant on antibody development.
Rosskopf-Streicher U; Johannes S; Cussler K
Dev Biol (Basel); 2002; 111():159-62. PubMed ID: 12678236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
